Nutrient sensing, growth and senescence by Carroll B & Korolchuk VI
 
 
 
 
 
Newcastle University ePrints | eprint.ncl.ac.uk 
Carroll B, Korolchuk VI. Nutrient sensing, growth and senescence. FEBS 
journal 2018, ePub ahead of print.
DOI link 
https://doi.org/10.1111/febs.14400 
ePrints link 
http://eprint.ncl.ac.uk/246790 
Date deposited 
12/03/2018 
Copyright 
© 2018 The Authors. The FEBS Journal published by John Wiley & Sons Ltd on behalf of 
Federation of European Biochemical Societies. 
This is an open access article under the terms of the Creative Commons Attribution 
License, which permits use, distribution and reproduction in any medium, provided the 
original work is properly cited.  
Licence 
This work is licensed under a Creative Commons Attribution 4.0 International License 
 
 
STATE-OF-THE-ART REVIEW
Nutrient sensing, growth and senescence
Bernadette Carroll and Viktor I. Korolchuk
Institute for Cell and Molecular Biosciences, Newcastle University, UK
Keywords
ageing; autophagy; growth; membrane
potential; mTORC1; primary cilia;
senescence
Correspondence
B. Carroll and V. I. Korolchuk, Institute for
Cell and Molecular Biosciences, Newcastle
University, Newcastle upon Tyne NE4 5PL,
UK
Fax: +44 191 248 1101
Tel: +44 191 248 1132(BC);
+44 191 248 1221(VIK)
E-mails: bernadette.carroll@ncl.ac.uk;
viktor.korolchuk@ncl.ac.uk
(Received 16 December 2017, revised 15
January 2018, accepted 30 January 2018)
doi:10.1111/febs.14400
Cell growth is dictated by a wide range of mitogenic signals, the amplitude
and relative contribution of which vary throughout development, differenti-
ation and in a tissue-specific manner. The ability to sense and appropri-
ately respond to changes in mitogens is fundamental to control cell
growth, and reduced responsiveness of nutrient sensing pathways is widely
associated with human disease and ageing. Cellular senescence is an impor-
tant tumour suppressor mechanism that is characterised by an irreversible
exit from the cell cycle in response to replicative exhaustion or excessive
DNA damage. Despite the fact that senescent cells can no longer divide,
they remain metabolically active and display a range of pro-growth pheno-
types that are supported in part by the mTORC1-autophagy signalling
axis. As our understanding of the basic mechanisms of controlling
mTORC1-autophagy activity and cell growth continues to expand, we are
able to explore how changes in nutrient sensing contribute to the acquisi-
tion and maintenance of cellular senescence. Furthermore, while the protec-
tive effect of senescence to limit cellular transformation is clear, more
recently, the age-related accumulation of these pro-inflammatory senescent
cells has been shown to contribute to a decline in organismal fitness. We
will further discuss whether dysregulation of nutrient sensing pathways can
be targeted to promote senescent cell death which would have important
implications for healthy ageing.
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Introduction
Growth needs to be tightly coordinated with the pres-
ence of nutrients and extracellular growth promoting
cues at the cellular, tissue and organismal level. Unsur-
prisingly, perturbations in nutrient and growth factor
sensing are tightly linked with human pathologies, par-
ticularly ageing and age-related disease such as cancer,
neurodegeneration and metabolic syndrome [1,2].
Understanding the basic mechanisms that maintain
nutrient homeostasis in a healthy state and impor-
tantly, exploring how they are perturbed in pathologies
is a thriving area of biomedical sciences. At the very
heart of cell growth regulation lies the interplay
between the mammalian target of rapamycin complex
1 (mTORC1), which promotes cellular anabolism, and
the catabolic autophagy pathway.
Mammalian target of rapamycin complex 1 is a sig-
nalling hub which receives and integrates multiple
inputs including the presence of growth factors, onco-
genes, energy in the form of ATP, oxygen, reactive
oxygen species and intracellular amino acids. Sensing
of these factors is facilitated by an array of dedicated
proteins which encompass the mTORC1 signalling net-
work and which have been described in detail in a
number of excellent reviews elsewhere [2–7]. Briefly,
mitogenic signals serve ultimately to control the sub-
cellular localisation and therefore activity of mTORC1
and its regulatory proteins. Growth factor-activated
receptors, cellular energy levels and amino acids such
as arginine control mTORC1 by regulating the interac-
tion of its master activator, the small GTPase Rheb
(Ras homologue enriched in brain) with a negative
regulator, tuberous sclerosis complex (TSC) [5,8–12].
In the absence of these factors, the TSC complex is
recruited to the surface of the lysosome where the
GTPase activating protein (GAP), TSC2 within the
complex binds to and facilitates GTP hydrolysis of
Rheb [9–12] as well as physically sheltering Rheb from
mTORC1 [12].
To become activated by Rheb, mTORC1 needs to
be recruited to the lysosomal surface by the family of
Rag small GTPases which are present in a heterodi-
meric complex consisting of Rag A or B in complex
with Rag C or D [2,6]. Unlike Rheb, Rag GTPases are
cytoplasmic proteins which are tethered to the lyso-
some by another protein complex, the Ragulator,
which further facilitates activation by GTP loading of
RagA/B in its capacity as a nucleotide exchange factor
(GEF) [2,6]. The amino acids arginine, leucine and
glutamine are sensed by several molecular mechanisms
all converging on and changing GTP/GDP binding
status of the Rag heterodimer [6]. The presence of
these amino acids allows Rheb to interact with Rag-
bound mTORC1 which results in its activation
although the underlying molecular mechanism remains
unknown. It has been proposed that following its acti-
vation, mTORC1 can be released from the lysosome
which allows it to phosphorylate its targets including
regulators of protein translation machinery p70-S6
kinase and 4E-BP1 [13]. Active mTORC1 also sup-
presses the catabolic autophagy pathway, a process
whereby intracellular components including damaged
or surplus proteins, protein aggregates, organelles and
pathogens are engulfed by a membrane to form vesi-
cles called autophagosomes. These eventually fuse with
the lysosome where their content is degraded and the
constituents are released back into cytoplasm to serve
in biosynthetic processes [3].
mTORC1 in senescence
In normal cells, the removal of mitogenic cues such as
growth factors and amino acids inactivates mTORC1,
slowing cell growth and activating autophagy to liber-
ate nutrients and support cell survival. However, in
some human disorders, mTORC1 does not respond
appropriately to nutritional cues which contribute to
pathological phenotypes. This can be exemplified using
cellular senescence where mTORC1 becomes resistant
to nutrient starvation [14,15] and rather, the kinase
complex is constitutively active (Fig. 1). This has been
associated with defects in both growth factor and
amino acid sensing pathways and in this review we will
discuss the mechanisms that contribute to dysregula-
tion of nutrient sensing and explore the repercussions
for our understanding of cell growth regulation in
health and disease.
Cellular senescence is a term to describe cells that
have irreversibly exited the cell cycle. Senescence is
classically considered to be a tumour suppressor mech-
anism that prevents potential cellular transformation
upon oncogene activation or excessive DNA damage.
At the same time, the age-related accumulation of
senescent cells has been implicated as an important
contributor to age-related decline in tissue and organ
fitness [16]. Cellular senescence was first described by
Leonard Hayflick upon the observation that primary
human diploid fibroblasts in culture can only divide a
finite number of times before exiting the cell cycle [17].
Subsequent research has implicated that telomere
shortening is an important inducer of cell senescence,
as well as excessive DNA damage from irradiation or
following the replicative burst associated with onco-
gene activation [16,18–21]. Activation of the DNA
damage response (DDR) via PIKK family members,
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ATM and ATR triggers a signalling cascade including
activation of p53 and the accumulation of cyclin-
dependent kinase inhibitors such as p16(INK4A), p19
(ARF) and p21(WAF1/CIP1) [16,20–22]. Despite the
fact that they can no longer divide, senescent cells are
extremely metabolically active and are fundamentally
characterised by many pro-growth phenotypes such as
an enlarged size, increased organelle content (including
mitochondria and lysosomes), increased metabolism
and the potent secretion of inflammatory mediators
[16,23–27]. This latter phenotype is referred to as
senescence-associated secretory phenotype (SASP) and
is associated with increased expression of cytokines
and chemokines such as IL6 and IL8 [27].
The activity of mTORC1 has been widely implicated
in driving many of these phenotypes and indeed the
observed insensitivity of mTORC1 to changes in the
balance of mitogenic cues is likely to have wide impli-
cations for protein translation and cell metabolism.
For example, mTORC1 can support mitochondrial
biogenesis and SASP via protein translation-dependent
mechanisms. Specifically, mTORC1 regulates transla-
tion of MK2/MAPKAPK2 which controls senescence
via phosphorylation of the RNA-binding protein,
ZFP36L1 preventing its binding to and degrading
SASP RNA transcripts [28]. Furthermore, mTORC1-
dependent translation of IL1A promotes transcription
of SASP factors such as IL6 via NF-kB [29]. The
mTORC1-dependent biogenesis of mitochondria via
PCG1b and the subsequent increase in intracellular
ROS is also important for activating senescence-
associated DDR and ultimately SASP [30] (See Fig. 1).
All of these reports use the mTORC1 inhibitor, rapa-
mycin to demonstrate the specific role for mTORC1 in
controlling SASP. Furthermore, rapamycin has been
comprehensively shown to be able to slow the induc-
tion of senescence downstream of inducible p21, oxida-
tive stress [31], DNA damage [32], oncogene activation
[33] and replicative exhaustion [33,34], demonstrating
the central importance of mTORC1 to acquisition of
senescence and driving senescence-associated pheno-
types. Furthermore, inhibition of growth factor sig-
nalling upstream of mTORC1 also slows senescence
acquisition [35].
Autophagy in senescence
Interestingly, in senescent cells, autophagy may
become partially uncoupled from mTORC1 signalling
and its inhibitory effect [14]. We have demonstrated
that autophagy flux, which reflects the activity of this
degradative system, is significantly increased in
Fig. 1. Dysregulation of growth factor sensing to mTORC1 and autophagy in senescence. In proliferating cells, growth factor removal
induces cilia growth which downregulates growth factor signalling, mTORC1 and expression of cell cycle inhibitor p16. In senescent cells,
cilia formation is abnormal (lack of elongation or increased length) which is a result of plasma membrane hypopolarisation, p16 or reduced
CP110 (negative regulator of cilium growth) expression. As a result, PI3K/Akt signalling to mTORC1 is persistent and starvation fails to
induce autophagy. Persistent growth factor and mTORC1 signalling may contribute to SASP. Red text indicates proteins/complexes that are
downregulated in senescence; Blue text indicates that the activity of protein/complexes is upregulated in senescence.
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senescent fibroblasts even in the presence of nutrients.
This correlates with increased levels of intracellular
amino acids both in fed and starved senescent cells. At
the same time, autophagy is not further upregulated
when cells are starved, consistently with the lack of
mTORC1 inactivation in these conditions. Together
with a well-documented expansion of the lysosomal
compartment, which is exploited in the Sen-b-Gal
labelling of senescent cells, these data suggest that the
entire autophagosome–lysosome system is upregulated
in senescence (Fig. 2). Indeed, several studies have
shown that autophagy is important for the mainte-
nance of senescence phenotypes and knockdown of the
essential autophagy genes Atg5 or Atg7 reduces SASP
and can bypass senescence [36,37].
A number of potential mechanisms can account for
the increased autophagy in senescent cells. Autophagy
has been suggested to increase in replicative senescence
due to the change in the expression ratio of BAG
(Bcl-2-associated athanogene) family of proteins.
Specifically, an increase in the BAG3/BAG1 ratio in
senescent cells may shift the balance of cellular prote-
olytic systems from proteasomal to autophagic degra-
dation [38]. Alternatively, expression of p16(INK4A),
p19(ARF) or p21(WAF1/CIP1) not only induces
senescence but also autophagy [39]. Furthermore, a
proteolytic Cyclin E fragment (p18-CycE) was shown
to facilitate DNA-damage-induced senescence and
autophagy induction [40]. The simultaneous mTORC1
and autophagy activation in senescence can be medi-
ated by a specialised intracellular structure called the
TOR-autophagy spatial coupling compartment
(TASCC) which is found in some forms of senescence,
particularly induced by oncogene expression [36].
TASCC was shown to allow compartmentalised gener-
ation of amino acids and other metabolites by autop-
hagy and simultaneously stimulate mTORC1 signalling
which promotes increased production of SASP factors,
thus facilitating acquisition of senescence phenotypes.
An MIT/TFE transcription factor-dependent mecha-
nism of simultaneous upregulation of autophagosome–
lysosome pathway and mTORC1 has also recently
been described in certain cancer models [41]. Here,
increased levels of MIT/TFE not only induce lysoso-
mal biogenesis, but also expression of RagD which
facilitates recruitment of mTORC1 to the lysosome
and its activation. Although we did not observe
differences in the expression of Rag GTPases in stress-
induced senescence (unpublished observations), this
mechanism may be potentially responsible for uncou-
pling of autophagosome–lysosome pathway from the
control by mTORC1 in other types of senescence.
Thus, different mechanisms, some of which are still to
be discovered, could be responsible for the senescence-
associated dysregulation of mTORC1/autophagy axis.
It is important to note that intracellular amino acid
concentrations in senescent cells are elevated only
when normalised to the cell number which is a com-
mon normalisation method [14]. However, senescent
cells are grossly enlarged compared to control cells
and when normalised by protein concentration, amino
acid concentrations are comparable to controls [14].
Although it could be envisaged that localised produc-
tion of amino acids produced by hyperactive lyso-
somes could be responsible for the persistent
mTORC1 in senescent cells, one should bear these
unique problems in mind when analysing observations
obtained in senescent cells.
Fig. 2. Senescence-associated changes in the autophagosome–lysosome pathway. Senescent cells are characterised by increased numbers
of autophagosomes and lysosomes, increasing flux through the pathway. This increases the generation of intracellular amino acids and
supports activity of mTOR pathway. At the same time, selective autophagy pathways such as mitophagy may be suppressed in
senescence. Some of the factors potentially leading to these changes in senescence are indicated. See text for further details.
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The issue is further confused by the fact that autop-
hagy is also suggested to prevent cellular senescence.
Thus, it was shown that ROS can lead to perturbation
of autophagic flux in senescent cells and restoration of
flux can be achieved by AMPK activation [42–44].
These conclusions seem to be consistent with the dis-
cussed above and well-documented suppression of
senescence by mTORC1 inhibitors which may, at least
in part, act by autophagy upregulation [30,44,45]. Sim-
ilarly, recent reports suggest that autophagy can allow
the bypass of RAS-induced senescence and facilitate
tumour growth [46]. Several potential arguments can
be offered to explain the contradictory role of autop-
hagy in senescence. For example, inhibition of
autophagy in young cells may result in senescence
whilst secondary upregulation of autophagy in senes-
cent cells may serve to maintain senescence phenotypes
such as increased metabolic activity. Additionally,
autophagy may differentially impact on the process of
senescence acquisition depending on the relative
expression of specific autophagy substrates. For exam-
ple, it has been suggested that selective autophagy may
prevent senescence by degrading a pro-senescence
factor GATA4 whilst senescence may indeed be facili-
tated by bulk autophagy through the TASCC [36,47].
This uncoupling of bulk and selective forms of
autophagy may be a general feature of senescence.
Selective autophagic degradation of dysfunctional
mitochondria, which is referred to as mitophagy is
suggested to decline in senescent cells independent of
the changes in the autophagosome–lysosome pathway
[48,49]. Several mechanisms may account for this phe-
nomenon. For example, cytoplasmic p53 upregulated
in senescent cells can interact with Parkin, an ubiquitin
ligase which tags defective mitochondria with ubiquitin
for degradation, and prevents its translocation to mito-
chondria [50]. Similarly, expression of mitophagy-
promoting protein kinase PINK1 becomes reduced
with aging, suppressing mitophagy and enhancing the
probability of senescence transition [51,52]. Finally, it
has been observed that in senescent cells the mitochon-
drial network becomes hyperfused which prevents
damaged mitochondria being engulfed by autophago-
somes [48]. Overall, an accumulation of dysfunctional
mitochondria as a result of mitophagy impairment
may lead to an increase in intracellular ROS and con-
tribute to the senescence phenotype as has been
recently demonstrated for muscle stellate cells. These
cells become defective in proliferation and differentia-
tion with age and eventually become senescent. At
least part of this process is mediated by defective mito-
phagy which promotes oxidative stress, de-repression
of p16(INK4A) and ultimately senescence [49,53].
Primary cilia in cell growth and
senescence
The unresponsiveness of mTORC1/autophagy to serum
starvation in senescence is associated with a number of
mechanisms including changes in membrane potential
which impacts on the formation of specialised immo-
bile membrane projections called primary cilia (PC).
Defects in PC formation supports elevated and persis-
tent PI3K/Akt signalling and loss of TSC2 recruitment
to the lysosome which in turn renders mTORC1 and
autophagy insensitive to growth factor withdrawal [14].
Work by others indicates that the interaction between
PC, PC-associated signalling, cell growth and senes-
cence appear to be very closely related (Fig. 1).
PC can be formed by almost all cells and function
to ‘sense’ the extracellular environment, both physical
and chemical signals, to control cell proliferation, dif-
ferentiation and renewal. There is increasing apprecia-
tion for the role of PC in sensing and integrating
mitogenic signals with wide implications for both basic
cell biology and disease. PC are formed by a charac-
teristic 9 + 0 microtubule arrangement, that is, they
lack the central microtubule doublet that would sup-
port motility of cilia [54]. They emanate from a basal
body which is derived from a centrosome and thus the
growth of PC is commonly associated with cells in a
quiescent or non-proliferating state. In fact, PC forma-
tion and cell proliferation were classically considered
to be mutually exclusive and evidence suggests that PC
function to inhibit or reduce cell growth. Defects in
PC formation or function therefore have obvious
repercussions for cancer and tumour suppressor mech-
anisms such as senescence.
Similar to senescent cells, mTORC1 in PC-deficient
cells is also resistant to serum starvation [14]. Further-
more, some ciliopathies, the term used to describe a
diverse group of genetic diseases that arise from PC
defects are associated with increased mTORC1 [55,56]
and increased senescence [57]. Polycystic kidney disease
which is characterised by cyst formation is associated
with elevated mTORC1 activity and increased cell size
[55]. This study demonstrated that in control mice and
cells, PC-dependent sensing of fluid flow in the kidney
promotes recruitment of the tumour suppressor LKB1
to cilia which leads to increased activation of AMPK
in the basal body and an inhibition of mTORC1 [55].
In models defective in PC formation (e.g. knockdown
of Kif3a and IFT88), mTORC1 activity is enhanced
and both in vivo and in vitro, inducible knockdown of
Kif3a results in increased cell size. Furthermore, the
ciliopathy nephronophthisis (NPH) causes kidney fail-
ure in children and young adults and is associated with
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increased senescence as indicated by increased p16
expression and Sen-b-Gal [57]. In this specific model,
senescence is associated with loss of function of the
transcription factor, GLIS2 (GLI-similar 2), which is
regulated by Hedgehog (Hh) signalling pathway (the
most well-studied pathway downstream of PC). Con-
sistent with this study, the Hh-responsive transcription
factor, GLI2 which can bind to the p16 promoter and
inhibit its expression [58] is downregulated in replica-
tive senescent cells [59] and in stress-induced senescent
cells (unpublished data). Thus, loss of GLI2 and the
subsequent failure to repress p16 expression may be a
universal contributor to the senescence phenotype.
At the same time, p16 inhibits the formation of PC in
human mammary epithelial cells (HMEC) [58], suggest-
ing that perhaps this mechanism could also serve to
reinforce the pro-growth phenotypes in senescence.
Why or how the levels of GLI2 are reduced in senes-
cence, however, is unknown. Equally, how this tran-
scription factor may impact on p21-mediated senescence
or in oncogene-induced senescence (OIS) remains to be
seen. Although these reports indicate senescent [14] and
p16 + [58] cells fail to form cilia, another report by
Breslin et al. (2014) show increased frequency and
length of PC in replicative senescent human fibroblasts
due to loss of the PC-inhibitory protein, CP110 [59].
While these disparities may be due to differences in
senescence induction, cell line or culture conditions, they
may equally indicate that a fine balance in PC forma-
tion, length and turnover is required for their proper
functioning and downstream signal transduction. For
example, very few ciliopathies are associated with a
complete loss of cilia and human disease is characterised
by a very diverse array of phenotypes.
Cell growth and membrane integrity
As we have discussed above, defects in PC elongation
have been associated with p16 expression [58], loss of
CP110 [59] and we have recently shown that hypopo-
larisation of cell plasma membrane can perturb cilia
growth [14] (Fig. 1). Membrane potential shows con-
siderable variation and is intimately linked to cell type,
function and degree of differentiation. Proliferating
fibroblasts have a resting membrane potential of
~ 20 mV, this decreases to ~ 70 mV in non-proliferating/
quiescent fibroblasts and our data indicate that this
hyperpolarisation is lost in senescence. Proper control
of membrane potential is mediated by K+ channels
and is required for cell growth, proliferation and the
proper balance of other intracellular ions such as cal-
cium. Numerous studies, in many model systems indi-
cate that K+ channel blockers inhibit cell proliferation
and that while cells in G0/G1 phase are more depo-
larised, hyperpolarisation of the membrane is required
for the transition from G1 to S phase [60]. Consistent
with this, changes in the potential of the plasma mem-
brane may play an influential role in senescence acqui-
sition as membrane hyperpolarisation (by activating
K+ channels using pinacidil) prolongs proliferation of
primary fibroblasts and delays the onset of senescence.
CDK inhibitors contribute to cell cycle arrest and
senescence to differing degrees in different cell types;
for example, p27 is important in oligodendrocyte
progenitor (OP) cells [61] whilst melanocytes show
preferential sensitivity to p16 expression [62]. Depolari-
sation-associated cell cycle arrest of OP cells was shown
to be dependent on p21 and p27 expression but not on
p16 or p19 [61]. Whether plasma membrane hypopolar-
isation contributes to cell cycle arrest in cell types where
senescence is dependent on p16 or p19 is currently
unknown. Moreover, there is little understanding about
the extent to which these cell-type-specific mechanisms
of cell cycle regulation contribute to senescence acquisi-
tion or senescence phenotypes, nor whether there is any
significance to the fact that senescent cells are arrested
in both G1 and G2 phases [63,64].
Our data indicate that defects in membrane potential
perturb PC formation and that hyperpolarisation of
the senescent cell membrane promotes elongation of
cilia which is sufficient to reduce activity of PI3K/Akt
pathway (in a cilia-dependent manner) and restores
sensitivity of mTORC1 in senescent cells to serum star-
vation. At present, it is not clear mechanistically how
cilia can directly impact on growth factor signalling.
On one hand, growth factor receptors such as PDGF-
R, EGF-R and IGF-R have been shown to localise and
potentially activated in the ciliary axoneme or basal
region [65,66,67]. At the same time, negative regulators
of growth factors signalling, such as the inositol
polyphosphate 5-phosphatase, INPP5E are recruited to
PC. Mutations in INPP5E have been shown to con-
tribute to polycystic kidney disease as a result of ele-
vated PI3K/Akt and mTORC1 signalling [68]. It is
possible that recruitment of such negative regulators to
the plasma membrane and PC are perturbed in senes-
cent cells and furthermore, it remains to be seen what
the repercussions are for growth factor RTK/receptor
localisation, activity or turnover in senescent cells with
hypopolarised plasma membranes. Restoring mem-
brane potential does not promote elongation of cilia to
the length seen in control cells [14], indicating that
while membrane potential is important there may be
other mechanisms controlling PC formation, possibly
including p16 expression and autophagy defects (see
specific sections elsewhere in this review).
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One further consideration regarding membrane
potential and senescence is whether only the plasma
membrane is affected. Changes in membrane potential
of the mitochondria, for example, are intimately linked
to its function and mitochondria have indeed been
shown to become depolarised in senescence [69]. At
least part of the mechanism underlying mitochondrial
membrane depolarisation is the increased ROS produc-
tion by dysfunctional mitochondria [69]. These mito-
chondrial phenotypes are the key mediators of ageing
and their dysfunction contributes to senescence acquisi-
tion and maintenance. It will be interesting to
investigate the relationship between plasma membrane
and mitochondrial membrane depolarisation. One
intriguing possibility is that mitochondrial dysfunction
results in the reduced levels of NADH which is required
for the maintenance of plasma membrane potential.
It is not clear at the moment why the membrane
potential of senescent cells is reduced, whether it is
associated with de-differentiation phenotypes, a direct
result of increased cell size, defects in specific protein
expression or changes in intracellular NADH and
ROS balance. Furthermore, hypopolarisation of the
cell membrane would impact intracellular calcium
levels, which can directly influence growth factor sig-
nalling and AMPK activity and it will be interesting to
explore how these changes, as well as the balance of
other ions affect signalling in senescent cells.
Autophagy and cilia
In addition to the role in growth factor signal trans-
duction, PC have a reciprocal regulatory relationship
with autophagy albeit one that is not completely clear
at present [56,70,71]. Autophagy, both basal and star-
vation-induced, can promote the degradation of speci-
fic ciliary proteins including IFT20 and the negative
regulator OFD1. As a result, autophagy has been
shown to both positively and negatively affect PC
growth [70,71]; indeed, autophagy perturbation in the
form of Atg5/Atg7 KO has been shown to both
increase [70] and reduce [56,71] PC formation and
length. An explanation for these differences remains
elusive but may perhaps be due to differences in cell
type or in response to specific stimulus. In the opposite
direction, PC and Hh signalling have been shown to
contribute to control of autophagosome formation
from the plasma membrane [70] although similarly,
other reports suggest Hh signalling negatively regulates
autophagy [72]. Further evidence suggests autophagy
may also participate in the cilia-LKB1-AMPK-mTOR
pathway in controlling fluid flow-dependent cell size in
the kidney [55,73]. One further consideration is that
autophagy may regulate the turnover of other PC pro-
teins and that the senescence-associated perturbation
of autophagy could impact on PC formation, turnover
and/or the subsequent recruitment of proteins control-
ling growth factor signalling.
mTORC1 responsiveness to other
mitogenic signals in senescence
While we and others have shown that mTORC1 and
autophagy are less sensitive to changes in nutrients, it
is not clear at present whether mTORC1 activity
responds properly to other stimuli. For example,
oxidative stress is a common hallmark of all forms of
senescence [74] and indeed exogenous oxidative stress,
for example, prolonged exposure to H2O2 [75] can pro-
mote senescence induction while hypoxia can suppress
senescence onset [74]. The translation and subsequent
activity of proteins important for controlling redox
balance such as HIF1a are under control of mTORC1
and therefore changes in mTORC1 responsiveness to
mitogenic cues may impact redox balance [76]. In the
reciprocal relationship, ROS has been demonstrated to
be able to both activate and inhibit mTORC1 depend-
ing on duration and concentration. Age-related mito-
chondrial stress can promote the ROS-dependent
activation of mTORC1 and induction of senescence
[77] and at the same time, increased mitochondrial
content in senescent cells is associated with increased
ROS which activates DDR signalling pathway to con-
trol mTORC1 [30]. So while there are clear links
between oxidative stress and senescence, the potential
specific role and mechanisms via which mTORC1 may
control this cross-talk requires more work.
The activity of mTORC1 is also controlled by energy
availability which is transduced via AMPK upon its
activation by increased intracellular AMP/ADP levels
(i.e. a drop in ATP) to TSC complex and Rheb activity.
Reports have shown that AMPK activity is reduced in
senescence and its activation may suppress oxidative
stress-induced senescence [42]; this correlates with the
fact that AMPK responsiveness reduces with age and its
activation can increase lifespan [78]. Other reports,
however, suggest AMPK is activated in senescence due
to elevated AMP:ATP ratio which has been associated
with reduced mitochondrial function and therefore ATP
production and that AMPK activation can drive senes-
cence [79–81] including via senescence-associated eleva-
tion of LKB1 [82]. We were unable to detect any gross
changes AMPK phosphorylation at steady state in
senescence human lung fibroblasts, but our insights into
nutrient sensing by mTORC1 suggest that responsive-
ness to energy levels (or Ca2+) may still be perturbed.
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Equally, we observed that TSC2 is not recruited
robustly to the lysosome in starved senescent cells which
supports mTORC1 activity and although we attributed
this to persistent PI3K/Akt signalling, we cannot rule
out that the responsiveness or activity of TSC2 to
AMPK signalling is disrupted in senescence [14].
Implications for ageing
Ageing and age-related diseases such as neurodegenera-
tion and cancer are some of the most costly burdens to
our society today, both economically and socially.
Identifying interventions that may support healthy age-
ing is one of the most important questions of our time.
Excitingly, the clearance of senescent cells has recently
been established as a powerful approach to promote
both health- and life-span extension in mice [83]. Thus,
it has been demonstrated that removal of senescent
cells can reverse age-related functional decline in the
heart, liver, bone, lung and prevent development of a
wide range of diseases including atherosclerosis and
diabetes mellitus. These findings have important poten-
tial implications for anti-ageing interventions in
humans. Indeed, human trials are underway where
senolytics will be tested for their beneficial effect in
age-related diseases, multimorbidity and frailty [83].
We have shown that correcting the phenotypes in
the nutrient sensing pathways of senescent cells can
promote selective senescent cell death in vitro [14]. As
such, our mechanistic investigations have added a
number of new drugs such as those targeting plasma
membrane polarisation (pinacidil), Akt and mTORC1
inhibitors (such as rapamycin and torin 1) and autop-
hagy blockers (chloroquine) to the growing list of
potential senolytics. Some of these interventions, such
as autophagy inhibition have already been demon-
strated to kill senescent cells using in vivo models of
anticancer chemotherapy-induced senescence [84].
Many other interventions such as rapamycin, caloric
restriction and exercise that have most consistent and
potent ability to extend health- and lifespan directly
influence mTORC1 and autophagy. It would therefore
be interesting to investigate whether any of the previ-
ously observed beneficial effects of these interventions
are mediated by their senolytic properties in vivo.
Conclusion
The realisation that senescent cells contribute to age-
related tissue decline has made the identification of
senolytic compounds an area of particular importance
to biomedicine. The acquisition and maintenance of
cellular senescence is associated with fundamental
rewiring of transcription, translation and metabolism
and a better understanding of these changes will
undoubtedly help support this quest to find healthy
ageing interventions.
In this review, we have discussed how the mTORC1-
autophagy signalling axis becomes unresponsive to
growth factors and amino acids in senescence and that
how this may support the characteristic pro-growth phe-
notypes. The true contribution of phenotypes we have
discussed here such as elevated basal autophagy, mem-
brane hypopolarisation and PC loss to senescence
remain important future directions for the field. Future
work will also help to unravel which of the extensive
senescence-associated changes reported are causal
mechanisms or consequences. For example, as we have
discussed, mTORC1 clearly regulates senescence-asso-
ciated phenotypes such as SASP; however, rapamycin
has never been demonstrated to rescue cell cycle arrest.
Thus, additional mechanisms upstream or parallel to
mTORC1 clearly control this aspect of senescence.
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